Health Grants
550 open opportunities. Open federal grants funding health, medicine, and public-health work, each with a plain-English eligibility summary, deadline, and award amount.
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $200K
An NIH (R21) exploratory grant funding invasive neural recording and stimulation studies in humans to understand neural circuitry underlying mental health disorders. A broad set of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $200,000. Technology and therapy development are out of scope, so this suits research institutions conducting specific neuroscience studies.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreIntegration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $500K
An NIH/NCI research project grant (R01) funding projects that integrate medical imaging with fluid-based (liquid biopsy) tumor monitoring during cancer therapy. Eligible applicants are domestic institutions such as universities, tribal governments, and community-based organizations; foreign organizations and foreign components are not eligible. The award is capped at about $500,000. This is an oncology research mechanism aimed at research institutions, not individuals or general nonprofits.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreNIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $50K
The NIH parent Small Research Grant (R03, clinical trial not allowed) supports small, short-term projects such as pilot and feasibility studies, secondary data analysis, and methodology development. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. The award is capped at about $50,000. The small budget suits research institutions pursuing limited-scope projects to generate preliminary data.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreNIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $150K
An NIH/NIAID Career Transition Award (K22) to help postdoctoral fellows move into assistant-professor or equivalent positions and launch independent biomedical research careers. Eligible applicants are domestic institutions such as universities, tribal governments, and community-based organizations; foreign organizations and foreign components are not eligible. The award is capped at about $150,000. This is a career-development mechanism oriented to early-career researchers working through a sponsoring institution.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreDevelopment of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R61/R33) opportunity funds discovery and early evaluation of candidate biomarkers for neurological and neuromuscular disorders, requiring preliminary human-sample evaluation. It is aimed at research and academic institutions; foreign organizations are not eligible to apply. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, including neurobiological and behavioral mechanisms and interdisciplinary collaboration. It targets research and academic institutions, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityMechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $500K
This NCI (R01) opportunity funds investigator-initiated studies on the mechanisms by which bariatric surgery affects cancer risk. It is intended for research and academic institutions; foreign organizations are not eligible to apply. The maximum award is about $500,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityDevelopment of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Up to $200K
This NIH ORIP (R21) opportunity funds research to develop, improve, and preserve animal models and related biological materials with broad applicability across multiple NIH institutes; single-disease or single-institute projects are out of scope. It is aimed at research and academic institutions; foreign organizations are not eligible. The maximum award is about $200,000.
ResearchersSchools & universitiesNarrow eligibilityLaboratories to Optimize Digital Health (R01 Clinical Trial Required)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIMH (R01) opportunity funds research testing strategies to increase the reach, efficiency, and effectiveness of digital mental health interventions, including clinical trials on established platforms. A clinical trial is required. It targets research and academic institutions rather than individuals or general nonprofits/small businesses; no specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityNIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIDCR (R03) small-grant program supports pilot or feasibility studies in oral, dental, and craniofacial research by scientists early in establishing an independent research career. It is intended for new-investigator researchers at eligible institutions; foreign organizations are not eligible to apply. No specific award amount is stated, though R03 awards are typically modest.
ResearchersSchools & universitiesNew orgs OKNarrow eligibilityMood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R21) opportunity funds translational research into mood and psychosis symptoms during the menopause transition, examining underlying neurobiological and behavioral mechanisms. It targets research and academic institutions and interdisciplinary research teams, not individuals or typical nonprofits/small businesses. No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityModular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Amount varies
This NIH (R01) opportunity supports investigator-initiated research in cancer control and population sciences, including epidemiology, survivorship, behavioral interventions, and health-data science. It is intended for research and academic institutions rather than individuals or general nonprofits/small businesses. No specific award amount is given.
ResearchersSchools & universitiesNarrow eligibilityMechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Due Jan 7, 2028National Institutes of Health · Amount varies
An NIH/NCI exploratory grant (R21, clinical trial not allowed) funding proof-of-concept studies on the mechanisms by which bariatric surgery affects cancer risk. A broad range of domestic and foreign institutions may apply, including universities, tribal governments, and community-based organizations. No specific award amount is stated. Projects must address feasibility not already established in the literature, so this suits research institutions with relevant preliminary direction.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreLimited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Due Jan 7, 2028National Institutes of Health · Up to $75K
A limited-competition NIH/NIDDK Small Grant (R03) available only to existing NIDDK-supported K01, K08, K23, and K25 career-award recipients, to support their transition to independent investigator status. A broad set of domestic and foreign institutions may apply on their behalf, but the underlying applicant must already hold a qualifying NIDDK K award. The grant is capped at about $75,000. This is restricted to current NIDDK career-award holders, not new applicants.
ResearchersSchools & universitiesGovernment / tribalNonprofits+2 moreStimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
Due Jan 10, 2028National Institutes of Health · Amount varies
An NIH (R38) award supporting in-depth research experiences for resident clinicians early in their careers to build a pipeline of clinician-investigators. Eligible applicants are domestic institutions and organizations such as universities, tribal governments, and faith- or community-based organizations; foreign organizations and foreign components are not eligible. No award amount is stated. This is a structured research-training mechanism aimed at academic and clinical institutions rather than individuals applying directly.
ResearchersSchools & universitiesGovernment / tribalNonprofits+1 moreDevelopment of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
Due Jan 25, 2028National Institutes of Health · $2M–$8M
An NIH construction grant (C06, clinical trial not allowed) funding the development or modernization of shared-use biomedical research facilities and HIV/AIDS research facilities. Eligibility details are in the NOFO; foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible. Awards range from about $2 million to $8 million. This is a facilities-construction mechanism for research institutions, and exact eligibility should be confirmed in the NOFO.
ResearchersSchools & universitiesLarge awardNarrow eligibilityBlueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Due Jan 28, 2028National Institutes of Health · Amount varies
Open to a broad range of applicants including universities, minority-serving institutions, tribal governments, faith- and community-based organizations, foreign organizations, and individuals or businesses developing their own devices under this NIH Blueprint MedTech UG3/UH3 (clinical trial optional). Funds translational and clinical-feasibility work to develop therapeutic and diagnostic devices for nervous-system and neuromuscular disorders, with access to NIH-funded consultants and contract research organizations. It is a milestone-driven cooperative agreement with NIH staff involvement; no specific award amount is listed.
NonprofitsResearchersSchools & universitiesGovernment / tribal+2 moreCommercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Due Jan 31, 2028Centers for Disease Control and Prevention - ERA · $150K–$975K
Open to universities and researchers, nonprofits, businesses (including small businesses), and individuals with expertise in commercial fishing and maritime safety. Funds research to improve worker safety in commercial fishing — vessel design, survival and emergency equipment, monitoring and communication systems. Awards run roughly $150,000–$975,000, administered by CDC/NIOSH.
ResearchersNonprofitsSmall businessIndividuals+1 moreCommercial Fishing Occupational Safety Training Project Grants (T03)
Due Jan 31, 2028Centers for Disease Control and Prevention - ERA · $250K–$975K
A CDC/NIOSH and Coast Guard training grant (T03) to develop and deliver safety training for U.S. commercial fishermen. Eligible applicants include school districts, public/Indian housing authorities, Native American tribal organizations, faith- or community-based organizations, regional organizations, bona fide state agents, and FFRDCs. Awards range from about $250,000 to $975,000. Eligibility is moderately broad across organizations but excludes individuals; review the listed categories to confirm fit.
NonprofitsGovernment / tribalSchools & universitiesLarge award+1 moreExpanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Due Feb 17, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government and tribal organizations; foreign organizations are not eligible. This NIH R21 funds exploratory, early-stage projects developing methods or agents to target 'undruggable' molecules in serious diseases. Award size isn't specified and follows standard NIH R21 limits; best suited to researchers pursuing high-risk, innovative therapeutics.
ResearchersSchools & universitiesNonprofitsGovernment / tribal